Atlas Trials

Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.

Clinical trial NCT05594602 · COMPLETED

Trial details

NCT number
NCT05594602
Sponsor
Enanta Pharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2022-10-06
Primary completion
2022-12-14
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.